Table of Contents

Morphine- and CaMKII-Dependent Enhancement of GIRK Channel Signaling in Hippocampal Neurons

  1. Paul A. Slesinger 1 , 2
  1. 1Peptide Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, California 92037,
  2. 2Biology Graduate Program, Department of Biology, University of California, San Diego, La Jolla, California, 92093,
  3. 3Department of Basic Neurosciences, Medical Faculty, CH-1211 Geneva, Switzerland,
  4. 4Clinic of Neurology, Department of Clinical Neurosciences, Geneva University Hospital, CH-1211 Geneva, Switzerland, and
  5. 5Department Ciencias Médicas, Facultad de Medicina, Universidad de Castilla-La Mancha, 02006 Albacete, Spain
  1. Correspondence should be addressed to Paul A. Slesinger, Peptide Biology Laboratory, the Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California 92037. slesinger{at}salk.edu
  • R. Nassirpour's present address: Senior Scientist, Exploratory Drug Safety Research and Development, Pfizer Inc., 1 Burtt Road, Andover, MA 01810.

Abstract

G-protein-gated inwardly rectifying potassium (GIRK) channels, which help control neuronal excitability, are important for the response to drugs of abuse. Here, we describe a novel pathway for morphine-dependent enhancement of GIRK channel signaling in hippocampal neurons. Morphine treatment for ∼20 h increased the colocalization of GIRK2 with PSD95, a dendritic spine marker. Western blot analysis and quantitative immunoelectron microscopy revealed an increase in GIRK2 protein and targeting to dendritic spines. In vivo administration of morphine also produced an upregulation of GIRK2 protein in the hippocampus. The mechanism engaged by morphine required elevated intracellular Ca2+ and was insensitive to pertussis toxin, implicating opioid receptors that may couple to Gq G-proteins. Met-enkephalin, but not the μ-selective (DAMGO) and δ-selective (DPDPE) opioid receptor agonists, mimicked the effect of morphine, suggesting involvement of a heterodimeric opioid receptor complex. Peptide (KN-93) inhibition of CaMKII prevented the morphine-dependent change in GIRK localization, whereas expression of a constitutively activated form of CaMKII mimicked the effects of morphine. Coincident with an increase in GIRK2 surface expression, functional analyses revealed that morphine treatment increased the size of serotonin-activated GIRK currents and Ba2+-sensitive basal K+ currents in neurons. These results demonstrate plasticity in neuronal GIRK signaling that may contribute to the abusive effects of morphine.

Related Article